Abstract
Enzyme load in pancreas has been considered a risk factor in the development of acute pancreatitis. In order to confirm this hypothesis our aim was to analyze the development and evolution of acute pancreatitis (AP) induced by bile-pancreatic duct obstruction (BPDO) after reducing the pancreatic enzyme content. L-364,718 – a potent CCK-receptor antagonist – was administered (0.1 mg/kg/day) for 7 days before inducing AP by BPDO. The course of AP was evaluated at different times from 1.5–48 h after BPDO. Amylase and trypsinogen contents and cytosolic calcium levels were measured by flow cytometry using specific antisera against pancreatic enzymes labelled with isothiocyanate of fluorescein and Fluo 3, respectively. The severity of the disease at the different stages was evaluated by measurements of amylase activity in ascites and plasma, percentage of pancreatic fluid and haematocrit. Electron microscopy study of the pancreas showed an increased number of zymogen granules spread through the acinar cells of control rats treated with L-364,718 for 7 days, however, total enzyme content in individual acinar cells was significantly (p < 0.01) diminished. AP significantly increased intracellular amylase and trypsinogen load from 3–12 h after BPDO, and prior L-364,718 treatment enhanced the blockade of enzyme secretion. As a result, acinar enzyme content was significantly increased from earlier stages (1.5 h after BPDO). In parallel, increased cytosolic calcium levels observed up to 24 h after BPDO appeared earlier in L-364,718-treated rats than in those not treated. The severity of AP seems to have been higher in rats previously treated with the CCK-receptor antagonist as indicated by the significantly higher pancreatic fluid and amylase activity in ascites and plasma observed at different times after BPDO. Our results indicate that there is no correlation between the severity of pancreatitis and the amount of enzymes accumulated in the pancreas before the disease is induced.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bialek R, Willemer S, Arnold R, Adler G: Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats. Scand J Gastroenterol 26: 190-196, 1991
Leach SD, Modlin IM, Scheele GA, Gorelick FS: Intracellular activation of digestive enzymes in rat pancreatic acini. Stimulation by high dose of cholecystokinin. J Clin Invest 87: 362-366, 1991
Saluja AK, Donovan EA, Yamanaka K, Yamaguchi Y, Hofbaver B, Steer ML: Caerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 113: 304-310, 1997
Manso MA, Orfao A, Tabernero MD, Vicente V, De Dios I: Changes in both the membrane and the enzyme content of individual zymogen granules are associated with sodium taurocholate-induced pancreatitis in rats. Clin Sci 94: 293-301, 1998
García Montero AC, Manso MA, Orfao A, Vicente S, De Dios I: Zymogen granule alterations in caerulein-induced pancreatitis developed during continuous hydrocortisone administration. Eur J Clin Invest 29: 496-503, 1999
Saluja AK, Bhagat L, Lee HS, Bathia M, Frossard JL, Steer ML: Secretagoge-induced digestive enzyme activation and cell injury in rat pancreatic acini. Am J Physiol 39: 6835-6842, 1999
Krüger B, Albrecht E, Lerch MM: The role of intracellular calcium signalling in premature protease activation and the onset of pancreatitis. Am J Pathol 157: 43-50, 2000
Machado M, Cunha J, Abdo E, Coelho A, Sampetri S, Kubrusli M: Does the pancreatic enzyme content modify the outcome of acute pancreatitis? Pancreas 21: 459, 2000
Manso MA, García Montero AC, Tabernero MD, Orfao A, De Dios I: The recovery of acute pancreatitis depends on the enzyme amount stored in zymogen granule at early stages. Mol Cell Biochem 200: 35- 41, 1999
Uruñuela A, Manso MA, Pinto RM, Orfao A, De Dios I: Enzyme load in pancreatic acinar cells is increased in the early stages of acute pancreatitis induced by duct obstruction in rats. Clin Sci 98: 143-150, 2000
Tachibana I, Kataoka K, Imoto M, Umehara K, Sasaki T, Yorizumi H, Kato M, Yamame Y, Kashima K: Effect of a new cholecystokinin antagonist KSG-504 on cerulein-induced acute pancreatitis in rats. Pancreas 8: 521, 1993
García Montero AC, Manso MA, Rodríguez AI, De Dios I: Therapeutic and protective effect of subcutaneous injections of L-364,718 on caerulein-induced pancreatitis. Pancreas 9: 309-315, 1994
Pescador R, Manso MA, Rebollo A, De Dios I: Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein. Pancreas 11: 165-172, 1995
Czakó L, Takaka T, Varga I, Hai DQ, Tiszlavick L, Hegyi P, Mandi Y, Matkovics B. Lanovics J: The pathogenesis of L-arginine-induced acute pancreatitis: Inflammatory mediators and endogenous cholecystokinin. J Physiol 94: 43-50, 2000
Ohshio G, Saluja A, Leli U, Sengupta A, Steer ML: Failure of a potent cholecystokinin antagonist to protect against diet-induced pancreatitis in mice. Pancreas 4: 739-743, 1989
Louie DS, Liang JP, Owyang C: Characterization of a new CCK antagonist, L-364,718, in vitro and in vivo studies. Am J Physiol 255: G261-G266, 1988
Rodríguez AI, Manso MA, García Montero AC, Orfao A, De Dios I: Long-term blockade of cholecystokinin (CCK): Effects of L-364, 718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion. Pancreas 15: 314-322, 1997
De Dios I, Rodríguez AI, García-Montero AC, Orfao A, Manso MA: Enzyme changes in zymogen CCK and in pancreatic secretion throughout long-term CCK treatment. Peptides 18: 101-110, 1997
Hickson JCD: The secretion of pancreatic juice in response to stimulation of the vagus nerves in the pig. J Physiol 206: 275-297, 1970
Vanderberghe PA, Ceuppens JL: Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T-lymphocytes with fluo-3, a fluorescent calcium indicator. J Immunol Meth 127: 197-205, 1990
De Dios I, Manso MA: Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of hydrocortisone-treated rats. Pancreas 9: 212-218, 1994
Zucker KA, Adrian TE, Bilchik AJ, Modlin IM: Effect of the CCK receptor antagonist L-364,718 on pancreatic growth in adult and developing animals. Am J Physiol 257: G511-G516, 1989
Ohshio G, Saluja A, Steer ML: Effects of short-term pancreatic duct obstruction in rats. Gastroenterology 100: 196-202, 1991
Uruñuela A, Manso MA, de la Mano A, Sevillano S, Orfao A, De Dios I: Asynchronous impairment of calcium homeostasis in different acinar cells after pancreatic duct obstruction in rat. Clin Sci 102: 615-622, 2002
Grady T, Mah'Moud M, Otani T, Rhee S, Lerch MM, Gorelick S: Zymogen proteolysis within the pancreatic acinar cell is associated with cellular injury. Am J Physiol 275: G1010-G1017, 1998
Lüthen R, Owen RL, Sarbia N, Grendell JH, Niederau C: Premature trypsinogen activation during cerulein pancreatitis in rats occurs inside pancreatic acinar cells. Pancreas 17: 38-43, 1998
Otsuki M: Pathophysiological role of cholecystokinin in humans. J Gastroenterol Hepatol 15 (suppl): D71-D83, 2000
Niederau C, Borchard F, Lüthen R, Niederau M: Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade. Hepato-Gastroenterol 43: 1442-1453, 1996
Scheele G, Adler G, Kern H: Exocytosis occurs at the lateral plasma membrane of the pancreatic acinar cell during supramaximal secretagogue stimulation. Gastroenterology 92: 345-353, 1987
Ward JB, Sutton R, Jenkins SA, Petersen OH: Progressive disruption of acinar cell calcium signaling is a early feature of cerulein-induced pancreatitis in mice. Gastroenterology 111: 481-491, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De La Mano, A., Sevillano, S., De Dios, I. et al. Low enzyme content in the pancreas does not reduce the severity of acute pancreatitis induced by bile-pancreatic duct obstruction. Mol Cell Biochem 240, 75–81 (2002). https://doi.org/10.1023/A:1020603724002
Issue Date:
DOI: https://doi.org/10.1023/A:1020603724002